top of page
  • Instagram
  • LinkedIn
  • YouTube

What Have We Learned About the Hormonal IUD?

Reports and results from hormonal IUD research in low- and middle-income settings

Filter by Country
Filter by Topic

September 2026

COF Monitoring & Learning Dashboard

This dashboard provides an aggregate view of progress and impact of the COF to increase visibility into the outcomes of funded COF grants for the broader SRH community. Data and insights on the dashboard are informed by a standardized set of indicators from COF M&L framework.

Introduction & Scale-Up

October 2026

COF Impact and Insights One Pager 2019-2025

This one-pager developed by CHAI summarizes the COF's experience to show what a better model for financing SRH product introduction can look like, how it's been impactful, and what we can learn to improve financing and grantmaking for SRH.

Introduction & Scale-Up, Market Assessment

September 2026

HIUD & Heavy Menstrual Bleeding Budget Impact Tool

Interactive budget analysis tool developed by FHI 360, enabling national governments and implementing partners to identify the budget impact of adding hormonal IUD to their menstrual health product mix. The tool allows for a range of editable inputs, including the overall distribution of menstrual health products and the amount to which HIUD shifts users away from other HMB treatment options.

Cost Assessment

September 2026

HIUD & Heavy Menstrual Bleeding Cost Effectiveness Summary - Nigeria

Two-page summary of cost-effectiveness analysis evaluating impact of hormonal IUD if introduced as a treatment option for heavy menstrual bleeding in Nigeria

Cost Assessment

September 2026

HIUD & Heavy Menstrual Bleeding Cost-Effectiveness Summary - Kenya

Two-page summary of cost-effectiveness analysis evaluating impact of hormonal IUD if introduced as a treatment option for heavy menstrual bleeding in Kenya

Cost Assessment

July 2026

SHINE Results Summaries

These results summary handouts capture key findings from implementation science research on hormonal IUD introduction conducted in Malawi, Kenya, and Nigeria. The results indicate strong user and provider interest, but persistent implementation and counseling challenges.

User Perspectives, Provider Perspectives

August 2026

HIUD & HMB: Cost Effectiveness Analysis

This summary presentation, compiled by Trinity Life Sciences from analysis conducted and reported by FHI 360, documents the hormonal IUD's economic impact when used as a front-line treatment for heavy menstrual bleeding in Kenya.

Cost Assessment

May 2026

UNFPA Commodity Funding for SRMNH Factsheet

Factsheet summarizing financing mechanisms for reproductive health commodities procured through UNFPA, including the administration of and eligibility for the New and Lesser-Used Commodities Fund.

Introduction & Scale-Up

February 2026

HIUD Scientific Evidence for Method Introduction

​

Research Coordination

February 2026

Provider Job Aid: Frequently Asked Technical Questions on the HIUD

This document is intended to provide quick answers to common questions hormonal IUD providers may have regarding method provision. The answers provided assume technical familiarity with family planning service provision and should not be read verbatim to clients. Instead, they can help build a provider’s knowledgebase to ensure accurate counseling, safe method insertion and removal, and appropriate management of side effects and complications.

Introduction & Scale-Up, Research Coordination

HIUD Access Group_Full Color Logo.png

A global consortium of family planning method introduction leadership dedicated to expanding access to the hormonal IUD

Sign up for our newsletter

© 2026 FHI 360

bottom of page